5-METHYL-1-(PIPERIDIN-4-YL)-1H-BENZO[D]IMIDAZOL-2(3H)-ONE HCL, 95.0%, 250mg

1-(3-Aminofuro[3,2-b]pyridin-2-yl)ethan-1-one, 95+%, 1g

cyclopropyl(3-pyridinyl)methanone, 95.0%, 10g

4-ethyl-5-[(4-isopropylphenoxy)methyl]-4H-1,2,4-triazole-3-thiol, 95.0%, 1g

2,3,4-Trifluoro-6-nitroaniline>98.0%(GC)1g

2-Iodo-1-(2,2,2-trifluoroethyl)-1H-indol-4-amine, 98%, 25g

5-(3-Nitrophenyl)-nicotinic acid, 95.0%, 250mg

3-Bromomethyl-7-methoxy-1,4-benzoxazin-2-one [for HPLC Labeling]>98.0%(T)100mg

Tris(4-(9H-carbazol-9-yl)phenyl)amine, 98%, 5g

1-tert-Butyl 3-ethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1,3(2H)-dicarboxylate, 95.0%, 250mg

5-methyl-3-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 1g

(3S,4R,5R)-5-((S)-1,2-Dihydroxyethyl)-3,4-dihydroxydihydrofuran-2(3H)-one, 95.0%, 500g

Formaldehyde solution, 2.5 l